Due to the COVID-19 situation we are postponing these meetings until further notice.
Sign up for more information when it becomes available.



Regional evening workshops

How to optimise therapy for cardiorenal patients

A focus on RAAS inhibition and hyperkalaemia management

Evening workshops from 18.30-20.30
Buffet supper from 17.30

Due to the COVID-19 situation we are postponing these meetings until further notice. We will provide more information in due course.

We are able to provide these meetings free of charge to healthcare professionals only. We thank Vifor Pharma UK Limited for their award of an unrestricted grant in support of these educational meetings.

Programme
  • 17.30   Arrival, registration and buffet supper
  • 18.30   Introduction
  • 18.35   Hyperkalaemia in patients with heart failure and optimising RAAS inhibition
  • 18.55   Case-based MDT discussion and questions
  • 19.10   Hyperkalaemia in the world of the nephrologist
  • 19.30   Case-based MDT discussion and questions
  • 19.45   Don’t let hyperkalaemia get you down
  • 20.05   Case-based MDT discussion and questions
  • 20.20   Meeting close
   

Speakers

Manchester 2020
  • Dr Matthew Kahn, Consultant Cardiologist
    (Pennine Acute Hospitals NHS Trust)
  • Professor Philip Kalra, Consultant Nephrologist
    (Salford Royal NHS Foundation Trust) and
    Professor of Renal Medicine (University of Manchester)
  • Mr Dan Terry, Heart Failure Nurse Specialist
    (Pennine Acute Hospitals NHS Trust)
  •  
Birmingham 2020
  • Professor Paul Kalra, Consultant Cardiologist
    (Portsmouth Hospitals NHS Trust)
  • Professor Charles Ferro, Consultant Nephrologist
    (University Hospitals NHS Foundation Trust)
  • Ms Helen Kelly, Heart Failure Nurse Specialist
    (University Hospitals NHS Foundation Trust)
  • Mr Andrew Griffiths, Heart Failure Nurse Specialist
    (University Hospitals Birmingham NHS Foundation Trust)
London 2020
  • Professor Paul Kalra, Consultant Cardiologist
    (Portsmouth Hospitals NHS Trust)
  • Professor Philip Kalra, Consultant Nephrologist
    (Salford Royal NHS Foundation Trust) and
    Professor of Renal Medicine (University of Manchester)
  • Ms Carys Barton, Heart Failure Nurse
    Consultant (Imperial College Healthcare NHS Trust)

What are they about?

We have been listening to your feedback that you would like more case-based and practical learning. We are delighted to be able offer these new evening workshops, led by experts in the field, that will discuss the practical approach to the management of hyperkalaemia in patients with cardiorenal disease.

This will include the approach to broad-spectrum presentations, from those with potentially life-threatening hyperkalaemia through to the impact of high potassium on the use of prognostically important renin-angiotensin-aldosterone system (RAAS) inhibitors. Using case examples, they will discuss and guide on how to optimally manage such patients and avoid pitfalls that might have adverse consequences to patients. Wherever possible, local pathways will be used and multidisciplinary discussion encouraged.

At the end of each workshop, delegates will have learned/contributed to multidisciplinary discussion around the following topics:

  • The prevalence of hyperkalaemia, its potential causes, presentation, and association with adverse outcomes
  • The prognostic benefit of RAAS inhibitors in patients with chronic heart failure and those with CKD and how hyperkalaemia may influence their prescription
  • The role of potassium binders in managing acute hyperkalaemia and facilitating the use of RAAS inhibitors
  • What national and international guidelines say
  • Review of local guidelines – are they contemporary?
  • Practical advice on how to manage hyperkalaemia in hospital and in the community
  • Multidisciplinary discussion around case histories including special groups, and clinical questions

Sign up for more information

Who can attend?

These workshops can only be attended by healthcare professionals. They are aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, care of the elderly, general medicine, general practitioners, clinical pharmacists and allied disciplines.

Funding

We thank Vifor Pharma UK Limited for their award of an unrestricted grant in support of these educational meetings.

Due to the COVID-19 situation we are postponing these meetings until further notice. We will provide more information in due course.